← Scroll for more →
CNS Pharmaceuticals, Inc. (CNSP)
Pharmaceutical Preparations
Latest Price
$5.00
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
12.45
P/B Ratio
0.40
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 1.35M | $6.0M | 92.09% | +1.28M | 2026-06-30 |
| Ikarian Capital, LLC | 135.8K | -- | 9.29% | +90.0K | 2026-06-30 |
| ADAR1 Capital Management, LLC | 70.0K | -- | 4.79% | -- | 2026-06-30 |
| Boothbay Fund Management, LLC | 13.5K | -- | 0.93% | -- | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 10.2K | -- | 0.70% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 7.0K | -- | 0.48% | -- | 2026-06-30 |
| UBS Group AG | 1.5K | -- | 0.10% | +732 | 2026-06-30 |
| Tower Research Capital LLC (TRC) | 799 | -- | 0.05% | -511 | 2026-06-30 |